MBA with Professional Certificate in Biotech M&A

Wednesday, 22 April 2026 21:19:46

International Students can apply

Apply Now     Viewbook

MBA with Professional Certificate in Biotech M&A

Overview

Biotech M&A

is a strategic approach to drive growth and innovation in the biotechnology industry. This MBA with Professional Certificate in Biotech M&A is designed for professionals seeking to develop expertise in managing mergers and acquisitions in biotech companies.

Learn how to navigate the complexities of biotech M&A, from deal structuring to integration and post-merger management.

Some key topics covered in this program include: strategic planning, financial analysis, and regulatory compliance.

Develop the skills and knowledge needed to succeed in biotech M&A, and take your career to the next level.

Explore this program further and discover how you can drive growth and innovation in the biotech industry.

MBA with Professional Certificate in Biotech M&A is a unique blend of business acumen and biotechnology expertise, designed to equip you with the skills to navigate the complex world of biotech mergers and acquisitions. This program offers key benefits such as enhanced career prospects, increased earning potential, and a competitive edge in the job market. You'll gain a deep understanding of biotech industry trends, regulatory frameworks, and strategic deal-making techniques. With a focus on practical application, you'll develop essential skills in financial analysis, market research, and negotiation. Unlock your full potential in the biotech M&A landscape. (11)

Entry requirements

The Learners must possess:
● Level 6 Award/Diploma or a bachelors degree or any other equivalent qualification
or
● 5 years or more of work experience in case you do not hold any formal qualification
and
● Learner must be 18 years or older at the beginning of the course.


International Students can apply

Joining our world will be life-changing with a student body representing over 157 nationalities.

LSIB is truly an international institution with history of welcoming students from around the world. With us, you're not just a student, you're a member.

Course Content

•
• Strategic Planning in Biotech M&A
•
• Biotech Industry Overview and Trends
•
• Financial Analysis and Valuation in M&A
•
• Regulatory Frameworks in Biotech M&A
•
• Due Diligence and Risk Assessment in Biotech M&A
•
• Negotiation and Deal Structuring in Biotech M&A
•
• Integration and Post-Merger Strategy in Biotech M&A
•
• Biotech M&A in Emerging Markets
•
• Intellectual Property and Patent Management in Biotech M&A
•
• Biotech M&A and Venture Capital

Assessment

The evaluation process is conducted through the submission of assignments, and there are no written examinations involved.

Fee and Payment Plans

30 to 40% Cheaper than most Universities and Colleges

Duration

The programme is available in two duration modes:

12 Months: GBP £7700
18 Months: GBP £6700
This programme does not have any additional costs.
The fee is payable in monthly, quarterly, half yearly instalments.
You can avail 5% discount if you pay the full fee upfront in 1 instalment

Payment plans

12 Months - GBP £7700

● Payment option (a) - GBP £770 x 10 monthly instalments
● Payment option (b) - GBP £2566 x 3 quarterly instalments
● Payment option (c) - GBP £3850 x 2 half yearly instalments
● Payment option (d) - GBP £7315 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

18 Months - GBP £6700

● Payment option (a) - GBP £478 x 14 monthly instalments
● Payment option (b) - GBP £1340 x 5 quarterly instalments
● Payment option (c) - GBP £2233 x 3 half yearly instalments
● Payment option (d) - GBP £6365 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

40% Cheaper

Our course fee is upto 40% cheaper than most universities and colleges.

Apply Now

Accreditation

 Stage 1 (Delivered by LSIB):
The programme involves delivery through on-line Learning Management System (LMS). This stage leads to award of Level 7 Diploma in Strategic Management and Leadership. Credits earned at this stage - 120 credits (60 ECTS).

Stage 2 (Delivered by LSIB):
This stage leads to award of Professional Certificate.

Stage 3 (Delivered by the University / awarding body)
On completion of the diploma programme you progress / Top up with Degree through a UK University for progression to the MBA degree. The stage 3 is delivered via distance learning by faculties from the University / awarding body. Credits earned at this stage - 60 credits (30 ECTS).

Apply Now

  • 1. Complete the online enrolment form and Pay enrolment fee of GBP £10.
  • 2. Wait for our email with course start dates and fee payment plans. Your course starts once you pay the course fee.
  • Apply Now
    •

Got questions? Get in touch

Chat with us: Click the live chat button

+44 75 2064 7455

admissions@lsib.co.uk

+44 (0) 20 3608 0144



Career path

Key facts about MBA with Professional Certificate in Biotech M&A

The MBA with Professional Certificate in Biotech M&A is a unique and specialized program designed to equip students with the knowledge and skills required to navigate the complex world of biotechnology mergers and acquisitions.
This program is ideal for professionals working in the biotech industry who want to enhance their understanding of M&A strategies and practices.
Through this program, students will learn about the latest trends and developments in biotech M&A, including deal-making, due diligence, and post-merger integration.
The learning outcomes of this program include the ability to analyze complex business problems, develop effective M&A strategies, and communicate with stakeholders.
The program is typically completed in 12-18 months and consists of a combination of online and on-campus courses.
The duration of the program allows students to balance their work and personal responsibilities while pursuing their academic goals.
The industry relevance of this program is high, as biotech M&A is a rapidly growing field with increasing demand for skilled professionals.
Companies in the biotech industry are looking for professionals who can navigate the complexities of M&A and drive growth through strategic acquisitions.
The MBA with Professional Certificate in Biotech M&A is a valuable asset for anyone looking to advance their career in the biotech industry.
It provides a unique combination of business and technical knowledge, making it an attractive option for professionals looking to transition into M&A roles.
The program is designed to be flexible and accommodating, with online courses that can be completed at the student's own pace.
This flexibility makes it an ideal option for working professionals who want to pursue their academic goals without disrupting their careers.
Overall, the MBA with Professional Certificate in Biotech M&A is a comprehensive and practical program that provides students with the knowledge and skills required to succeed in the biotech M&A industry.

Why this course?

Biotech M&A has become a crucial aspect of the life sciences industry, with the global market expected to reach $1.4 trillion by 2025, growing at a CAGR of 10.5% (Source: MarketsandMarkets). In the UK, the biotech sector is a significant contributor to the economy, with over 1,000 biotech companies employing over 20,000 people (Source: Biotechnology and Biological Sciences Research Council).
Year Growth Rate
2015-2019 8.5%
2020-2024 10.2%

Who should enrol in MBA with Professional Certificate in Biotech M&A?

Ideal Audience for MBA with Professional Certificate in Biotech M&A Professionals seeking to bridge the gap between business and biotechnology, with a focus on mergers and acquisitions, are the primary target audience for this program.
Key Characteristics: - Business professionals with a background in biotechnology or a related field, - Those looking to transition into the biotech industry, - Executives seeking to enhance their knowledge of biotech M&A, - Professionals working in the pharmaceutical, biotech, or medical device industries.
UK-Specific Statistics: - The UK biotech industry is valued at £14.8 billion, with over 1,500 biotech companies operating in the country (Source: Biotech UK). - The number of biotech jobs in the UK has increased by 10% in the past year, with over 20,000 jobs available (Source: BioIndustry Association).
Career Outcomes: - Senior roles in biotech M&A, - Business development and strategy, - Investment and venture capital, - Regulatory affairs and compliance.